Daily FNArena News

Now that investors are returning to commodity markets, Macquarie offers some tips for where to seek exposure.

Barclays Capital examines the Chinese copper market to see how it is travelling and what the outlook is for the world’s largest consumer.

At least one broker is worried Wesfarmers is heading to hell in a handcart. Another sees an extraordinary buying opportunity.

New debt covenants mean either a discounted asset sale or a dilutive equity issue for PaperlinX.

Where is the US dollar going? Standard Chartered thinks that it all comes down to your investment timeframe.

With the market bailout expected to cost up to US$1 trillion, the US’ huge budget deficit is set to get a lot worse, which should be bad news for the US dollar.

ANZ expects commodity prices will continue to trend lower in coming months, with the direction of the US dollar a key variable at present.

Weaker Chinese consumption and growing stockpiles is likely to put pressure on copper prices.

Even uranium prices are being dragged into the turmoil that is currently defining financial markets.

Sigma Pharmaceuticals’ first half profit was lower than expected, leading brokers to predict the company will do it tough in meeting its full year targets.